Steffen Wildum

2.3k total citations
34 papers, 1.2k citations indexed

About

Steffen Wildum is a scholar working on Epidemiology, Infectious Diseases and Virology. According to data from OpenAlex, Steffen Wildum has authored 34 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Epidemiology, 18 papers in Infectious Diseases and 11 papers in Virology. Recurrent topics in Steffen Wildum's work include Respiratory viral infections research (11 papers), HIV Research and Treatment (11 papers) and Influenza Virus Research Studies (10 papers). Steffen Wildum is often cited by papers focused on Respiratory viral infections research (11 papers), HIV Research and Treatment (11 papers) and Influenza Virus Research Studies (10 papers). Steffen Wildum collaborates with scholars based in Switzerland, Germany and United States. Steffen Wildum's co-authors include Frank Kirchhoff, Michael Schindler, Jan Münch, Stefan Binder, Joachim Forner, Holger Zimmermann, Peter Lischka, Neil Collinson, Helga Ruebsamen‐Schaeff and John A. T. Young and has published in prestigious journals such as New England Journal of Medicine, Nucleic Acids Research and Hepatology.

In The Last Decade

Steffen Wildum

34 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Steffen Wildum Switzerland	19	646	374	339	296	248	34	1.2k
Elena Giorgi United States	17	327 0.5×	744 2.0×	651 1.9×	288 1.0×	246 1.0×	43	1.3k
Denys Brand France	20	410 0.6×	478 1.3×	401 1.2×	201 0.7×	240 1.0×	41	1.1k
Emanuela Giombini Italy	17	500 0.8×	493 1.3×	355 1.0×	500 1.7×	50 0.2×	49	1.1k
Beatriz Pacheco United States	17	277 0.4×	743 2.0×	461 1.4×	212 0.7×	371 1.5×	32	1.0k
Gabriella Rozera Italy	16	228 0.4×	315 0.8×	342 1.0×	249 0.8×	80 0.3×	55	786
Udayan Chatterji United States	28	789 1.2×	769 2.1×	372 1.1×	855 2.9×	419 1.7×	51	2.0k
Julia Bitzegeio Germany	15	587 0.9×	517 1.4×	293 0.9×	200 0.7×	371 1.5×	19	1.3k
Steven P. Weinheimer United States	21	1.4k 2.2×	528 1.4×	514 1.5×	261 0.9×	341 1.4×	31	2.0k
Marilyn Lewis United Kingdom	14	265 0.4×	1.0k 2.8×	803 2.4×	255 0.9×	243 1.0×	25	1.2k
Yoshiyuki Yokomaku Japan	20	283 0.4×	699 1.9×	654 1.9×	366 1.2×	193 0.8×	60	1.1k

Countries citing papers authored by Steffen Wildum

Since Specialization

Citations

This map shows the geographic impact of Steffen Wildum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steffen Wildum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steffen Wildum more than expected).

Fields of papers citing papers by Steffen Wildum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steffen Wildum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steffen Wildum. The network helps show where Steffen Wildum may publish in the future.

Co-authorship network of co-authors of Steffen Wildum

This figure shows the co-authorship network connecting the top 25 collaborators of Steffen Wildum. A scholar is included among the top collaborators of Steffen Wildum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steffen Wildum. Steffen Wildum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Monto, Arnold S., Corrado Bernasconi, Bin Cao, et al.. (2025). Efficacy of Baloxavir Treatment in Preventing Transmission of Influenza. New England Journal of Medicine. 392(16). 1582–1593. 8 indexed citations

Bauer, Rebecca N., Anastasia Teterina, Haridha Shivram, et al.. (2023). Prognostic value of severe acute respiratory syndrome coronavirus‐2 viral load and antibodies in patients hospitalized with COVID‐19. Clinical and Translational Science. 16(6). 1049–1062. 6 indexed citations

Yılmaz, Gürdal, Jesus Abraham Simón Campos, Keith Pietropaolo, et al.. (2023). Oral Bemnifosbuvir (AT-527) Vs Placebo in Patients With mild-to-moderate COVID-19 in an Outpatient Setting (MORNINGSKY). Future Virology. 18(13). 839–853. 7 indexed citations

Mifsud, Edin, Steffen Wildum, Takao Shishido, et al.. (2022). Assessing the fitness of a dual-antiviral drug resistant human influenza virus in the ferret model. Communications Biology. 5(1). 1026–1026. 7 indexed citations

Wildum, Steffen, Manasa Suresh, Guido Steiner, et al.. (2022). Toll-Like Receptor 7 Agonist RG7854 Mediates Therapeutic Efficacy and Seroconversion in Woodchucks With Chronic Hepatitis B. Frontiers in Immunology. 13. 884113–884113. 6 indexed citations

Kumar, Deepali, Michael G. Ison, Jean‐Paul Mira, et al.. (2022). Combining baloxavir marboxil with standard-of-care neuraminidase inhibitor in patients hospitalised with severe influenza (FLAGSTONE): a randomised, parallel-group, double-blind, placebo-controlled, superiority trial. The Lancet Infectious Diseases. 22(5). 718–730. 59 indexed citations

Lee, Leo, Jie Zhou, Rebecca Frise, et al.. (2021). Evaluating the fitness of PA/I38T-substituted influenza A viruses with reduced baloxavir susceptibility in a competitive mixtures ferret model. PLoS Pathogens. 17(5). e1009527–e1009527. 29 indexed citations

Baker, Jeffrey P., S. Block, Balpreet Matharu, et al.. (2020). Baloxavir Marboxil Single-dose Treatment in Influenza-infected Children. The Pediatric Infectious Disease Journal. 39(8). 700–705. 62 indexed citations

Hashimoto, Takashi, Keiko Baba, Satoshi Hata, et al.. (2020). Comprehensive assessment of amino acid substitutions in the trimeric RNA polymerase complex of influenza A virus detected in clinical trials of baloxavir marboxil. Influenza and Other Respiratory Viruses. 15(3). 389–395. 24 indexed citations

10.

Lee, Leo, Jie Zhou, Rebecca Frise, et al.. (2020). Baloxavir treatment of ferrets infected with influenza A(H1N1)pdm09 virus reduces onward transmission. PLoS Pathogens. 16(4). e1008395–e1008395. 31 indexed citations

11.

García-Alcalde, Fernando, Steffen Wildum, Saskia L. Smits, et al.. (2019). Machine-learning based patient classification using Hepatitis B virus full-length genome quasispecies from Asian and European cohorts. Scientific Reports. 9(1). 18892–18892. 21 indexed citations

12.

Zhou, Zheng, Taishan Hu, Xue Zhou, et al.. (2017). Heteroaryldihydropyrimidine (HAP) and Sulfamoylbenzamide (SBA) Inhibit Hepatitis B Virus Replication by Different Molecular Mechanisms. Scientific Reports. 7(1). 42374–42374. 117 indexed citations

13.

Sauter, Daniel, Dominik Hotter, Benoît Van Driessche, et al.. (2015). Differential Regulation of NF-κB-Mediated Proviral and Antiviral Host Gene Expression by Primate Lentiviral Nef and Vpu Proteins. Cell Reports. 10(4). 586–599. 88 indexed citations

14.

Wildum, Steffen, et al.. (2013). In VitroandIn VivoActivities of AIC292, a Novel HIV-1 Nonnucleoside Reverse Transcriptase Inhibitor. Antimicrobial Agents and Chemotherapy. 57(11). 5320–5329. 7 indexed citations

15.

Schindler, Michael, Steffen Wildum, Nicoletta Casartelli, Margherita Doria, & Frank Kirchhoff. (2007). Nef alleles from children with non-progressive HIV-1 infection modulate MHC-II expression more efficiently than those from rapid progressors. AIDS. 21(9). 1103–1107. 23 indexed citations

16.

Forner, Joachim, et al.. (2007). Mapping of mitochondrial mRNA termini in Arabidopsis thaliana : t-elements contribute to 5′ and 3′ end formation. Nucleic Acids Research. 35(11). 3676–3692. 109 indexed citations

17.

Hanna, Zaher, Chunyan Hu, Patrick W. Vincent, et al.. (2007). Primary Human Immunodeficiency Virus Type 1 Nef Alleles Show Major Differences in Pathogenicity in Transgenic Mice. Journal of Virology. 81(9). 4677–4693. 20 indexed citations

18.

Rajan, Devi, Steffen Wildum, Elke Rücker, Michael Schindler, & Frank Kirchhoff. (2006). Effect of R77Q, R77A and R80A changes in Vpr on HIV-1 replication and CD4 T cell depletion in human lymphoid tissue ex vivo. AIDS. 20(6). 831–836. 31 indexed citations

19.

Münch, Jan, et al.. (2005). The role of upstream U3 sequences in HIV-1 replication and CD4+ T cell depletion in human lymphoid tissue ex vivo. Virology. 341(2). 313–320. 13 indexed citations

20.

Greenough, Thomas C., et al.. (2003). Alterations in HIV-1 LTR promoter activity during AIDS progression. Virology. 317(1). 109–118. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact